anti-N-methyl-D-aspartate receptor encephalitis (anti-NMDAR encephalitis)

1 total trials 1 recruiting

Filter these 1 trials by phase, country, sponsor and more.

Open in Search →

A Phase-2b, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-NMDA Receptor Enc … Recruiting

2023-504686-23-00 4 2024-12-10

Showing 1–1 of 1 trials